# Avalo Therapeutics, Inc.: Form DEF 14A, filed May 1, 2025

- Company: [Avalo Therapeutics, Inc.](/companies/avtx.md) (CIK 1534120)
- Form: DEF 14A
- Filed: 2025-05-01
- Accepted by EDGAR: May 1, 2025, 07:00 ET
- Period: 2025-06-17
- Accession: 0001628280-25-021311
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1534120/000162828025021311/avtx-20250501.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1534120/000162828025021311/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1534120/000162828025021311/avtx-20250501.htm

Filed May 1, 2025.
Source: SEC EDGAR, the filing index for accession 0001628280-25-021311. Last ingested by Listed: Nov 6, 2026, 12:42 ET. No prices; not investment advice.